Novo Nordisk A/S (NYSE:NVO)

46.79
Delayed Data
As of May 17
 0.00 / 0.00%
Today’s Change
41.23
Today|||52-Week Range
52.83
+1.56%
Year-to-Date

Today’s Trading

Previous close46.79
Today’s open46.80
Day’s range46.75 - 47.11
Volume1,027,966
Average volume (3 months)1,351,009
Market cap$86.3B
Data as of 4:02pm ET, 05/17/2019

Growth & Valuation

Earnings growth (last year)+8.07%
Earnings growth (this year)+0.28%
Earnings growth (next 5 years)+8.90%
Revenue growth (last year)+4.51%
P/E ratio19.7
Price/Sales6.31
Price/Book14.40

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.27-0.57%
AZNAstraZeneca-0.02-0.05%
GSKGlaxoSmithKline+0.12+0.31%
CELGCelgene-0.09-0.09%
Data as of 4:02pm ET, 05/17/2019

Financials

Next reporting dateAugust 9, 2019
EPS forecast (this quarter)$0.61
Annual revenue (last year)$17.7B
Annual profit (last year)$6.1B
Net profit margin34.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts